Lexicon Pharmaceuticals
Clinical trials sponsored by Lexicon Pharmaceuticals, explained in plain language.
-
New drug tested for debilitating shingles pain
Symptom relief CompletedThis study tested whether an investigational drug called LX9211 could safely reduce the chronic nerve pain that persists after a shingles rash heals, known as postherpetic neuralgia. About 80 adults with moderate to severe pain for at least 3 months received either the drug or a …
Phase: PHASE2 • Sponsor: Lexicon Pharmaceuticals • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
New drug tested for relief of diabetic nerve pain
Symptom relief CompletedThis study tested whether an investigational drug called LX9211 could reduce pain from diabetic nerve damage. 496 adults with long-term diabetic nerve pain received either the drug or a placebo for 8 weeks. Researchers measured changes in daily pain scores, burning sensations, an…
Phase: PHASE2 • Sponsor: Lexicon Pharmaceuticals • Aim: Symptom relief
Last updated Mar 25, 2026 14:07 UTC